Malaria Diagnosis and Treatment

Disease Fundamentals

Malaria is a potentially fatal mosquito-borne disease caused by Plasmodium parasites transmitted through the bite of infected female Anopheles mosquitoes, with P. falciparum being the most lethal species and responsible for the majority of deaths, particularly in sub-Saharan Africa 1, 2
The Centers for Disease Control and Prevention recommends that any febrile patient with recent travel to an endemic area requires immediate malaria screening, as delayed diagnosis of P. falciparum increases mortality 6

Transmission occurs through bites of infected female Anopheles mosquitoes between dusk and dawn 3
The World Health Organization notes that less common routes include blood transfusion, congenital transmission from mother to fetus, and nosocomial exposure 1
Geographic distribution includes Central and South America, sub-Saharan Africa, the Indian Subcontinent, Southeast Asia, the Middle East, and Oceania 1, 4

Fever with "flu-like" symptoms including chills, headache, myalgia, arthralgia, and malaise are the hallmark presentation 1, 6
Approximately 50% of patients are afebrile at presentation despite having a history of fever 3
The American Society of Tropical Medicine and Hygiene states that gastrointestinal symptoms (nausea, vomiting, diarrhea) and respiratory symptoms (cough) commonly occur 6
Splenomegaly has a likelihood ratio of 6.6 for diagnosis 6
Thrombocytopenia (<150,000/mL) occurs in 70-79% of patients and represents the most frequent laboratory abnormality 6

The Centers for Disease Control and Prevention recommends that a single negative blood smear cannot rule out malaria—three negative smears at 12-hour intervals are necessary to exclude the diagnosis 6
Direct microscopy of Giemsa-stained blood smears remains the reference standard for diagnosis, according to the World Health Organization 6
Rapid diagnostic tests serve as important adjunctive tools but should not replace microscopy, as stated by the American Society of Tropical Medicine and Hygiene 6

The World Health Organization recommends artemisinin-based combination therapy as first-line treatment for uncomplicated P. falciparum malaria 6
The Centers for Disease Control and Prevention states that P. vivax and P. ovale require additional therapy with an 8-aminoquinoline (primaquine or tafenoquine) to eradicate dormant liver hypnozoites and prevent relapses 6

The Centers for Disease Control and Prevention recommends that all travelers to malaria-endemic regions should take chemoprophylaxis before, during, and after travel 1, 7
Mefloquine is recommended for travelers at risk of chloroquine-resistant P. falciparum infection, according to the World Health Organization 1, 7
The American Society of Tropical Medicine and Hygiene states that alternative options for those unable to take mefloquine include doxycycline alone, or chloroquine with standby Fansidar treatment 5, 1

The Centers for Disease Control and Prevention notes that children commonly present with fever, cough, headaches, malaise, vomiting, and diarrhea 6
Pregnant women traveling to endemic areas require careful counseling about risks and appropriate prophylaxis options, as stated by the American College of Obstetricians and Gynecologists 6

The World Health Organization recommends that immediately screen for malaria with blood smears if any travel to endemic areas within the past year 3, 6
Obtain three blood smears at 12-hour intervals if initial smear is negative but clinical suspicion remains high, according to the Centers for Disease Control and Prevention 6
Identify species and assess for severe malaria criteria (altered consciousness, seizures, respiratory distress, shock, jaundice, severe anemia, acidosis, high parasitemia), as stated by the American Society of Tropical Medicine and Hygiene 6